XML 58 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaboration, Development and Supply Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2022
Oct. 31, 2022
Aug. 31, 2022
Sep. 30, 2021
May 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Oct. 31, 2021
Jan. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Account Receivable           $ 1,346   $ 1,346   $ 15,600    
Revenue recognized           167,735 $ 108,270 538,191 $ 244,372      
Accrued liabilities           38,209   38,209   49,796    
Inventory write-off               14,485 0      
Modified Purchase Order [Member]                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue recognized           53,200   53,200        
CpG 1018 adjuvant                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue recognized           87,500   201,100        
CpG 1018 adjuvant | Forecast [Member]                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Final payment for remaining quantities $ 29,300                      
CEPI Partners [Member] | Reservation Agreement                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Increase in interest free unsecured forgiveable loan maximum borrowing capacity         $ 77,400              
Interest free unsecured forgiveable loan Maximum borrowing capacity         $ 176,400              
Clover                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue recognized             52,400   58,200      
Advance payment received     $ 68,000                  
Cancellation Fees     24,100                  
Inventory write-off           14,500            
Clover | CpG 1018 adjuvant | Modified Purchase Order [Member]                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Final payment for remaining quantities     $ 14,600                  
Clover | CpG 1018 adjuvant | Forecast [Member]                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Potential future collection receivable   $ 10,000                    
Clover | Supply Agreement                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Deferred revenue           53,500   53,500   191,100    
Accounts Receivable Net Current           2,500   2,500   2,100    
Contract asset balance           71,300   71,300   62,500    
Medigen | Supply Agreement                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue recognized             6,900   24,400      
Accounts Receivable Net Current                   2,400    
Valneva SE                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Advance payment from customer                     $ 55,400  
Consideration Allocated To The Remaining Performance Obligation                     $ 55,400  
Deferred revenue           55,400   55,400        
Valneva SE | Supply Agreement                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Deferred revenue           0   0   55,400    
Revenue recognized               68,000 89,400      
Accounts Receivable Net Current                   0    
Biological E. Limited | Supply Agreement                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Deferred revenue           33,900   33,900   103,300    
Revenue recognized           27,600 $ 25,000 146,000 $ 25,900      
Accounts Receivable Net Current           98,100   98,100   96,100    
PT Bio Farma (Persero) | Supply Agreement                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Deferred revenue           0   0        
Revenue recognized           11,200   25,400        
Accounts Receivable Net Current           100   100        
U.S. Department of Defense                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue recognized           3,900   6,600        
Proceeds from grant       $ 22,000                
CEPI Member                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Interest- free unsecured forgivable loan                       $ 99,000
Advance payment from customer           175,100   175,100        
Long-term deferred revenue                   5,400    
Account Receivable           0   0   14,600    
Accrued liabilities           $ 107,700   $ 107,700   $ 128,800